— For those on active therapy, 80% had increased antibody levels, study showed by Mike Bassett A third dose of Pfizer's COVID-19 vaccine (BNT162b2; Comirnaty) could offer increased protection for cancer patients on active treatment, a new study suggested, as these...
By Ithai Waldhorn, et al. Abstract We had previously reported short-term efficacy, immunogenicity and safety of BNT162b2 vaccine among cancer patients with solid tumors. We aimed to evaluate these outcomes at 6-months post-vaccination. Study cohort comprised of...
— Most patients on active treatment remained seropositive at 4 months by Mike Bassett Cancer patients on active treatment achieved sustained responses to the Pfizer/BioNTech COVID-19 vaccine, though at reduced antibody levels versus healthy controls, according to...
A new study has found that the COVID-19 pandemic contributed to significant disruptions in breast, colorectal, and cervical cancer screenings at federally qualified health systems spanning 15 states across the United States. The postponed screenings have created...
In a U.S. and Swiss study, nearly all patients with cancer developed an immune response to COVID-19 mRNA vaccines 3 to 4 weeks after receiving their second dose. However, a small group of the patients exhibited no response, raising questions about how their protection...
6/18/2021 ~ The ASCO Post ~ By Matthew Stenger All-Cause Mortality in COVID-19–Positive and COVID-19–Negative Patients With Cancer In a large cohort study reported by Sharafeldin et al in the Journal of Clinical Oncology, researchers from the National COVID Cohort...
June 11, 2021 ~ MedPage Today ~ by Mike Bassett Cancer Patients See High Seroconversion Rates After COVID Vax — Dampened responses seen in those with hematological malignancies, however Patients with cancer who were vaccinated against COVID-19 achieved high...
Lymph Node Findings on PET: Cancer or COVID Vaccine? — Post-jab radiotracer uptake "could prompt unnecessary biopsies and treatments" by Mike Bassett, Staff Writer, MedPage Today May 26, 2021 Positron emission tomography (PET) imaging of cancer patients after they...
May 26, 2021 ~ Nature ~ Lewis Au, et al. Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2 Abstract Patients with cancer are currently prioritized in coronavirus disease 2019 (COVID-19) vaccination programs globally, which...
https://ascopost.com/news/april-2021/recent-studies-explore-efficacy-of-covid-19-vaccination-in-patients-with-leukemia-and-myeloma/?utm_source=TAP%2DEN%2D041921%2DTrending%5FLeukemia&utm_medium=email&utm_term=68712af64a8c3dc56f28c8c568893ce1 Originally published by: ...
https://slate.com/technology/2021/04/cancer-covid-remission-Integrative Therapies,Treatment-viruses.html Originally published by: Slate.com Author: Anna Goshua Date: 4/29/2021 Categories: Integrative Therapies,Treatment
ACS Journals, April 27, 2021 by Christine Miaskowski RN, PhD, et al. Loneliness and symptom burden in oncology patients during the COVID-19 pandemic Abstract BACKGROUND Loneliness and social isolation are significant public health problems that are being exacerbated...
https://ascopubs.org/doi/full/10.1200/OP.20.00995 Originally published by: JCO Author: Mary Steimer et al. Date: 4/1/2021 Categories: Integrative Therapies,Treatment
https://www.medpagetoday.com/radiology/therapeuticradiology/91887?xid=nl_mpt_SROncology_2021-04-01&eun=g1435132d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=OncoUpdate_040121&utm_term=NL_Spec_Oncology_Update_Active Originally published by: Med Page Today...
MedPage Today: "Barely one-quarter of patients with cancer obtained protection against COVID-19 after one dose of the Pfizer/BioNTech vaccine, a prospective study showed. The data found a "strikingly low" 28% immune efficacy rate in patients with cancer, including...